ArticleFrontiers in immunology2025
A 41-marker 37-color full spectrum flow cytometry panel for the deep immunophenotyping of human peripheral and liver natural killer cells.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Peripheral cytotoxic immune profiles in hepatobiliary surgical patients.Frontiers in immunology · 2026Article
- Comprehensive immune profiling of human peripheral blood mononuclear cells using two complementary spectral flow cytometry panels encompassing 60 unique markers.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural killer cells (NK cells) are granular lymphocytes with cytotoxic activity that have a role in both innate and adaptive immune responses. NK cells consist of a diverse array of phenotypes with specific functions imposed by the microenvironment. Liver NK cells are an abundant lymphocyte population playing a key role in tuning immune responses under physiological and pathological conditions. For example, NK cell functional and phenotypic changes occur during liver cancer progression and correlate with disease prognosis. As liver cancer has the second-highest mortality rate among solid cancers, it is important to define the composition and the dynamics of the liver and peripheral NK cell compartment both in health and disease state. In-depth analysis of the phenotypes and functional status of NK cells and their frequencies will expand our knowledge on their role in maintaining immune tolerance, disease progression, and aid the development of novel treatments. We present here a 41-marker 37-color spectral flow cytometry panel for the in-depth phenotyping of human peripheral and liver NK cells. This paper describes the first spectral flow cytometry panel with 35 markers potentially co-expressed on one cell type (NK cells) including the panel design process, sample preparation, staining protocol, quality control metrics, acquisition protocol and workflows to analyze NK cells in the periphery and liver. NK cell subsets and phenotypes were distinguished by including markers of differentiation, maturation, tissue residency, migratory potential, functional status, key transcription factors, and immune checkpoint molecules. Liver-type ILC1s (Lt-ILC1s) could be identified by inclusion of additional markers and modification of published gating strategies. Furthermore, we describe the dynamics of peripheral and liver NK cells. Finally, we show the validity of markers included to indicate NK cell dysfunction in samples of patients with Hepatocellular Carcinoma (HCC). This high parameter high resolution panel provides a key tool for in-depth delineation of distinct NK cell subsets in the periphery and in liver, in health and disease state. It allows for the robust identification of NK cells subsets with low frequencies and can effectively be used for samples with limited cell numbers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.